reports
Maria Vara
- Maria Vara
Alex Cogut ... (+2)
- Alex Cogut
- Ingird Gafanhão
Jyseleca growth stalls in Q1 update, guidance to be revised
Galapagos reported its Q1 2023 results with Jyseleca coming in 14% below consensus at EUR 26.7m (Q4 2022: EUR 27.1m) as last year's unfavorable EMA PRAC review is putting pressure on JAK inhibitors. Thus, the company plan to most likely lower its FY guidance of EUR 140-160m in the H1 update. Nevert
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.